[
    [
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：前三季度营收增长超35%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "前三季",
                    "营收",
                    "增长",
                    "35%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：前三季度营收增长超35%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：前三季度营收同比增长36%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "前三季",
                    "营收",
                    "增长",
                    "36%"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：前三季度营收同比增长36%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物前三季度营收增长超35% 13价肺炎结合疫苗批签发增长明显",
            "features": {
                "keywords": [
                    "沃森生物",
                    "前三季",
                    "营收",
                    "增长",
                    "35%",
                    "13价肺炎结合疫苗",
                    "批签发",
                    "增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物前三季度营收增长超35% 13价肺炎结合疫苗批签发增长明显",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物公布三季报 前三季净利减少16.33%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "三季报",
                    "净利",
                    "减少",
                    "16.33%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物公布三季报 前三季净利减少16.33%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "图解沃森生物三季报：第三季度单季净利润同比减87.92%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "三季报",
                    "第三季度",
                    "净利",
                    "减少",
                    "87.92%"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "图解沃森生物三季报：第三季度单季净利润同比减87.92%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：第三季度扣非净利降61.34%至1.45亿元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "第三季度",
                    "扣非净利",
                    "下降",
                    "61.34%",
                    "1.45亿"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：第三季度扣非净利降61.34%至1.45亿元",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：第三季度净利4517万元，同比下降87.92%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "第三季度",
                    "净利",
                    "4517万",
                    "下降",
                    "87.92%"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：第三季度净利4517万元，同比下降87.92%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：2021年第三季度净利润约4517万元，同比下降87.92%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2021年",
                    "第三季度",
                    "净利",
                    "4517万",
                    "下降",
                    "87.92%"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：2021年第三季度净利润约4517万元，同比下降87.92%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：前三季度净利3.6亿元 同比下降16.33%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "前三季",
                    "净利",
                    "3.6亿",
                    "下降",
                    "16.33%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：前三季度净利3.6亿元 同比下降16.33%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "沃森生物：前三季度净利减少16.33% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "前三季",
                    "净利",
                    "减少",
                    "16.33%",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：前三季度净利减少16.33% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-30",
            "original_text": "疫苗股午后异动，康希诺涨超4%",
            "features": {
                "keywords": [
                    "疫苗股",
                    "午后",
                    "异动",
                    "康希诺",
                    "涨超",
                    "4%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗股午后异动，康希诺涨超4%",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]